Speaker illustration

Doctor Annette Galema-Boers

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

Member of:

In 2011 she started her Master Advanced Nursing Practice (MANP) en completed this study in 2013. From this time she worked as a nurse practitioner in care for patient with familial hypercholesterolemia (FH), combined with research in this population. In 2018 she finished her PhD. Since 2015 she is president of the nurse practitioners in the Erasmus MC, the Netherlands.

Residual cardiovascular risk in patients with familial hypercholesterolemia

Event: EuroHeartCare 2017

Topic: Prevention and rehabilitation from knowledge to practice

Session: Moderated poster session 2 - Prevention and rehabilitation from knowledge to practice

Thumbnail

Real world experience of efficacy and safety using Proprotein convertase subtilisin / Kexin 9 (PCSK9) inhibition in patients with familial hypercholesterolemia

Event: EuroHeartCare 2017

Topic: Prevention and rehabilitation from knowledge to practice

Session: Prevention and rehabilitation from knowledge to practice

Thumbnail

Real world experience of efficacy and safety using proprotein convertase subtilisin / Kexin 9 (PCSK9) inhibition in patients with Familial Hypercholesterolemia

Event: EuroPrevent 2017

Topic: Lipids

Session: Diabetes/ Lipids/Obesity/Nutrition_Part 1

Thumbnail

Residual cardiovascular risk in patients with Familial Hypercholesterolemia

Event: EuroPrevent 2017

Topic: Lipids

Session: Diabetes/ Lipids/Obesity/Nutrition_Part 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk